Chordia Therapeutics Inc.
Chordia Therapeutics Inc.
Share · JP3283730004 (XTKS)
Overview
No Price
Closing Price XTKS 27.10.2025: 115,00 JPY
27.10.2025 05:38
Current Prices from Chordia Therapeutics Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
190A.T
JPY
27.10.2025 05:38
115,00 JPY
-3,00 JPY
-2,54 %
Share Float & Liquidity
Free Float 25,50 %
Shares Float 17,59 M
Shares Outstanding 68,99 M
Company Profile for Chordia Therapeutics Inc. Share
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.
Get up to date insights from finAgent about Chordia Therapeutics Inc.

Company Data

Name Chordia Therapeutics Inc.
Company Chordia Therapeutics Inc.
Website https://www.chordiatherapeutics.com/en/index.html
Primary Exchange XTKS Tokyo
ISIN JP3283730004
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Hiroshi Miyake
Market Capitalization 13 Mrd.
Country Japan
Currency JPY
Employees 0,0 T
Address 26-1, Muraoka-Higashi 2-chome, Fujisawa, 251-0012 Fujisawa
IPO Date 2024-06-14

Ticker Symbols

Name Symbol
Tokyo 190A.T
More Shares
Investors who hold Chordia Therapeutics Inc. also have the following shares in their portfolio:
Konndor Industries Ltd.
Konndor Industries Ltd. Share
MEXIKO 23/28
MEXIKO 23/28 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025